ChiCTR2200061108Not yet recruiting
Untitled Trial
A Randomized Controlled Clinical Study to Explore the Clinical Value of MRD Monitoring for Adjuvant Targeted Therapy
Peking University People’s HospitalPhase 4Chinese Clinical Trial Registry
Study focus
- Disease/Condition
- lung cancer
Sponsor & location
- Primary sponsor
- Peking University People’s Hospital
- Location
- China
Timeline & enrollment
- Phase
- Phase 4
- Start date
- N/A
- End date
- Jul 31, 2029
ICD-10 classifications
Carcinoma in situ: Bronchus and lungSecondary malignant neoplasm of lungMalignant neoplasm of bronchus and lungMalignant neoplasm: Bronchus or lung, unspecifiedMalignant neoplasm: Overlapping lesion of bronchus and lung
Data source
- Registry
- Chinese Clinical Trial Registry
- Trial ID
- ChiCTR2200061108
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for ChiCTR2200061108 through Pure Global AI's free database. This Phase 4 trial is sponsored by Peking University People’s Hospital and is currently Not yet recruiting. The study focuses on lung cancer.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Chinese Clinical Trial Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.